WO1997037028A2 - Ribose-5-phosphate isomerase (d-ribose-5-phosphate cetol isomerase, ec 5.3.1.6) - Google Patents
Ribose-5-phosphate isomerase (d-ribose-5-phosphate cetol isomerase, ec 5.3.1.6) Download PDFInfo
- Publication number
- WO1997037028A2 WO1997037028A2 PCT/EP1997/001539 EP9701539W WO9737028A2 WO 1997037028 A2 WO1997037028 A2 WO 1997037028A2 EP 9701539 W EP9701539 W EP 9701539W WO 9737028 A2 WO9737028 A2 WO 9737028A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- phosphate
- ribose
- phosphate isomerase
- sequence
- protein
- Prior art date
Links
- 102000007382 Ribose-5-phosphate isomerase Human genes 0.000 title claims abstract description 30
- 108020005610 ribose 5-phosphate isomerase Proteins 0.000 title claims abstract description 30
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 35
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 28
- 150000001413 amino acids Chemical class 0.000 claims abstract description 23
- 230000000694 effects Effects 0.000 claims abstract description 15
- 230000002363 herbicidal effect Effects 0.000 claims abstract description 9
- 229910019142 PO4 Inorganic materials 0.000 claims description 25
- 239000010452 phosphate Substances 0.000 claims description 24
- 102000004195 Isomerases Human genes 0.000 claims description 16
- 108090000769 Isomerases Proteins 0.000 claims description 16
- 238000012360 testing method Methods 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 9
- 239000004009 herbicide Substances 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 230000002401 inhibitory effect Effects 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000013598 vector Substances 0.000 claims description 3
- 230000033228 biological regulation Effects 0.000 claims description 2
- 239000003112 inhibitor Substances 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 239000000969 carrier Substances 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 239000003394 isomerase inhibitor Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 abstract description 7
- 108020004707 nucleic acids Proteins 0.000 abstract description 6
- 102000039446 nucleic acids Human genes 0.000 abstract description 6
- 239000013543 active substance Substances 0.000 abstract description 4
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 description 14
- 108090000765 processed proteins & peptides Proteins 0.000 description 10
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 230000002829 reductive effect Effects 0.000 description 8
- 241000219315 Spinacia Species 0.000 description 7
- 235000009337 Spinacia oleracea Nutrition 0.000 description 7
- 239000002299 complementary DNA Substances 0.000 description 7
- 108020004414 DNA Proteins 0.000 description 6
- 108091034117 Oligonucleotide Proteins 0.000 description 6
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 5
- -1 pentose phosphate Chemical class 0.000 description 5
- 210000002706 plastid Anatomy 0.000 description 5
- 239000002243 precursor Substances 0.000 description 5
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- PPQRONHOSHZGFQ-LMVFSUKVSA-N aldehydo-D-ribose 5-phosphate Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PPQRONHOSHZGFQ-LMVFSUKVSA-N 0.000 description 4
- 239000001569 carbon dioxide Substances 0.000 description 4
- 229910002092 carbon dioxide Inorganic materials 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 230000001590 oxidative effect Effects 0.000 description 4
- 230000004108 pentose phosphate pathway Effects 0.000 description 4
- 235000021317 phosphate Nutrition 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 241000244203 Caenorhabditis elegans Species 0.000 description 3
- 108700010070 Codon Usage Proteins 0.000 description 3
- NGHMDNPXVRFFGS-IUYQGCFVSA-N D-erythrose 4-phosphate Chemical compound O=C[C@H](O)[C@H](O)COP(O)(O)=O NGHMDNPXVRFFGS-IUYQGCFVSA-N 0.000 description 3
- FNZLKVNUWIIPSJ-UHNVWZDZSA-N D-ribulose 5-phosphate Chemical compound OCC(=O)[C@H](O)[C@H](O)COP(O)(O)=O FNZLKVNUWIIPSJ-UHNVWZDZSA-N 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- FNZLKVNUWIIPSJ-UHFFFAOYSA-N Rbl5P Natural products OCC(=O)C(O)C(O)COP(O)(O)=O FNZLKVNUWIIPSJ-UHFFFAOYSA-N 0.000 description 3
- 108020004511 Recombinant DNA Proteins 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 description 3
- 230000029553 photosynthesis Effects 0.000 description 3
- 238000010672 photosynthesis Methods 0.000 description 3
- 230000000243 photosynthetic effect Effects 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 3
- OSJPPGNTCRNQQC-UHFFFAOYSA-N 3-phosphoglyceric acid Chemical compound OC(=O)C(O)COP(O)(O)=O OSJPPGNTCRNQQC-UHFFFAOYSA-N 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- 241000606790 Haemophilus Species 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 108010029485 Protein Isoforms Proteins 0.000 description 2
- 102000001708 Protein Isoforms Human genes 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 2
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 2
- 241000192593 Synechocystis sp. PCC 6803 Species 0.000 description 2
- 102000014701 Transketolase Human genes 0.000 description 2
- 108010043652 Transketolase Proteins 0.000 description 2
- 102000005924 Triose-Phosphate Isomerase Human genes 0.000 description 2
- 108700015934 Triose-phosphate isomerases Proteins 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000021523 carboxylation Effects 0.000 description 2
- 238000006473 carboxylation reaction Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000037353 metabolic pathway Effects 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 description 2
- 235000011009 potassium phosphates Nutrition 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- LXJXRIRHZLFYRP-VKHMYHEASA-L (R)-2-Hydroxy-3-(phosphonooxy)-propanal Natural products O=C[C@H](O)COP([O-])([O-])=O LXJXRIRHZLFYRP-VKHMYHEASA-L 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- VAKURJMAYXIWPT-UHFFFAOYSA-N 3-benzyl-1,1-dichlorourea Chemical compound ClN(C(NCC1=CC=CC=C1)=O)Cl VAKURJMAYXIWPT-UHFFFAOYSA-N 0.000 description 1
- OSJPPGNTCRNQQC-UWTATZPHSA-N 3-phospho-D-glyceric acid Chemical compound OC(=O)[C@H](O)COP(O)(O)=O OSJPPGNTCRNQQC-UWTATZPHSA-N 0.000 description 1
- PQGCEDQWHSBAJP-TXICZTDVSA-N 5-O-phosphono-alpha-D-ribofuranosyl diphosphate Chemical compound O[C@H]1[C@@H](O)[C@@H](O[P@](O)(=O)OP(O)(O)=O)O[C@@H]1COP(O)(O)=O PQGCEDQWHSBAJP-TXICZTDVSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- GSXOAOHZAIYLCY-UHFFFAOYSA-N D-F6P Natural products OCC(=O)C(O)C(O)C(O)COP(O)(O)=O GSXOAOHZAIYLCY-UHFFFAOYSA-N 0.000 description 1
- NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 1
- LXJXRIRHZLFYRP-VKHMYHEASA-N D-glyceraldehyde 3-phosphate Chemical compound O=C[C@H](O)COP(O)(O)=O LXJXRIRHZLFYRP-VKHMYHEASA-N 0.000 description 1
- YAHZABJORDUQGO-NQXXGFSBSA-N D-ribulose 1,5-bisphosphate Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)C(=O)COP(O)(O)=O YAHZABJORDUQGO-NQXXGFSBSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 1
- 102000000587 Glycerolphosphate Dehydrogenase Human genes 0.000 description 1
- 108010041921 Glycerolphosphate Dehydrogenase Proteins 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 1
- 241000208125 Nicotiana Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108020000772 Ribose-Phosphate Pyrophosphokinase Proteins 0.000 description 1
- 102000000439 Ribose-phosphate pyrophosphokinase Human genes 0.000 description 1
- 102100039270 Ribulose-phosphate 3-epimerase Human genes 0.000 description 1
- 108060007030 Ribulose-phosphate 3-epimerase Proteins 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000192584 Synechocystis Species 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 241000723873 Tobacco mosaic virus Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- BGWGXPAPYGQALX-ARQDHWQXSA-N beta-D-fructofuranose 6-phosphate Chemical compound OC[C@@]1(O)O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O BGWGXPAPYGQALX-ARQDHWQXSA-N 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 230000003851 biochemical process Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 150000001722 carbon compounds Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000004110 gluconeogenesis Effects 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 239000000710 homodimer Substances 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 229940027941 immunoglobulin g Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- FIKAKWIAUPDISJ-UHFFFAOYSA-L paraquat dichloride Chemical compound [Cl-].[Cl-].C1=C[N+](C)=CC=C1C1=CC=[N+](C)C=C1 FIKAKWIAUPDISJ-UHFFFAOYSA-L 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 229930029653 phosphoenolpyruvate Natural products 0.000 description 1
- DTBNBXWJWCWCIK-UHFFFAOYSA-K phosphonatoenolpyruvate Chemical compound [O-]C(=O)C(=C)OP([O-])([O-])=O DTBNBXWJWCWCIK-UHFFFAOYSA-K 0.000 description 1
- 108010080971 phosphoribulokinase Proteins 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000019525 primary metabolic process Effects 0.000 description 1
- 108020001580 protein domains Proteins 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 238000000734 protein sequencing Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000024053 secondary metabolic process Effects 0.000 description 1
- JDTUMPKOJBQPKX-GBNDHIKLSA-N sedoheptulose 7-phosphate Chemical compound OCC(=O)[C@@H](O)[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O JDTUMPKOJBQPKX-GBNDHIKLSA-N 0.000 description 1
- JXOHGGNKMLTUBP-HSUXUTPPSA-N shikimic acid Chemical compound O[C@@H]1CC(C(O)=O)=C[C@@H](O)[C@H]1O JXOHGGNKMLTUBP-HSUXUTPPSA-N 0.000 description 1
- JXOHGGNKMLTUBP-JKUQZMGJSA-N shikimic acid Natural products O[C@@H]1CC(C(O)=O)=C[C@H](O)[C@@H]1O JXOHGGNKMLTUBP-JKUQZMGJSA-N 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/533—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving isomerase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
Definitions
- Ribose 5-phosphate isomerase (D-ribose 5-phosphate ketol isomerase, EC 5.3.1.6)
- the present invention relates to proteins with Ribcse-5-phosphate isomerase activity, their use in test systems, and to nucleic acids which code for these proteins.
- Plants are able to form organic compounds with the formation of oxygen using light energy from atmospheric carbon dioxide. This process is called photosynthesis.
- the complex reactions that lead to carbon dioxide fixation are divided into light and dark reactions.
- the light reaction serves to provide energy in the form of ATP and reduction equivalents in the form of NADPH.
- the dark reaction reductive pentose phosphate cycle or Calvin cycle
- these compounds are used for the synthesis of organic carbon compounds.
- Some of the known herbicides e.g. dichlorophenylmethyl urea or paraquat
- the dark reaction is not used as a target for herbicides.
- the plastidic ribose 5-phosphate isomerase occupies a special position, which catalyzes the following reaction:
- the enzyme has an amphibolic function, i.e. it is part of both the reductive pentosephosphate cycle (Calvin cycle) and the oxidative pentosephosphate pathway and thus has an important function in photosynthetic and non-photosynthetic tissues.
- Ribose 5-phosphate is converted via the phosphoribosyl pyrophosphate synthetase into phosphoribosyl pyrophosphate, which acts as a ribose 5-phosphate donor molecule in tryptophan and nucleotide biosynthesis.
- the erythrose-4-phosphate, sedoheptulose-7-phosphate, glyceraldehyde-3-phosphate and fructose are derived from the ribose-5-phosphate and ribulose-5-phosphate via the plastid transketolase and the ribulose-5-phosphate-3-epimerase - 6-phosphate.
- Erythrose-4-phosphate is an intermediary between primary and secondary metabolism.
- erythrose-4-phosphate flows into the shikimate path, which leads to the synthesis of aromatic amino acids and phenolic substances.
- Exported triose phosphates serve as substrates for glycolysis and gluconeogenesis in the cytoplasm.
- Fructose-6-phosphate is used as a precursor for the production of starch in the plastids.
- Ribulose-5-phosphate is converted, depending on ATP, by the phosphoribulokinase into ribulose-1, 5-bisphosphate, which functions as the primary carbon dioxide acceptor.
- the plastid ribose 5-phosphate isomerase is present as a homodimer with a relative molecular mass of approx. 53 kDa ⁇ Rutner,
- the object of the present invention was to provide a vegetable 35 ribose-5-phosphate isomerase in pure form by cloning the corresponding gene.
- amino acid sequence shown in SEQ ID NO 2 is based on the translation of the cDNA sequence shown in SEQ ID NO 1.
- the protein shown in SEQ ID NO 2 is a so-called precursor protein consisting of 289 amino acids.
- the mature protein arises from the precursor form by splitting off the chloroplastic där transit peptide, which consists of 50 amino acids according to an N-terminal sequencing of the mature protein.
- Both the precursor protein and proteins derived therefrom by substitution, deletion or insertion of amino acids and which still have ribose 5-phosphate isomerase activity belong to the proteins according to the invention.
- Substitution means the exchange of one or more amino acids by one or more other amino acids. So-called conservative exchanges are preferably carried out, in which the new amino acid has a similar property to the original amino acid, for example replacement of Glu by Asp, Val by Ile, Ser by Thr.
- Deletion is the replacement of an amino acid with a direct link; preferred positions for deletions are the termini of the polypeptide and the links between the individual protein domains.
- Inserts are insertions of amino acids into the polypeptide chain, whereby a direct bond is formally replaced by one or more amino acids.
- Proteins which are formed from N-terminal shortenings by 20 to 100 amino acids from SEQ ID NO 2 are particularly preferred.
- the invention further relates to nucleic acids which code for the abovementioned proteins.
- Suitable nucleic acid sequences can be obtained by back-translating the polypeptide sequence according to the genetic code. Those codons are preferably used for this which are frequently used according to the organism-specific "codon usage". The codon usage can easily be determined on the basis of computer evaluations of other known genes of the organism in question.
- ribose 5-phosphate isomerase If the plant ribose 5-phosphate isomerase is to be expressed, for example, in a bacterium, it is often advantageous to use the "codon usage" of the bacterium for the back translation.
- the invention furthermore relates to vectors for producing transgenic plants which contain the nucleic acids coding for the ribose 5-phosphate isomerase according to the invention together with functional regulation signals.
- Regulatory signals include the constitutive gene expression-promoting promoters such as the 35S CaMV promoter ⁇ Franck et al. , 1980, Cell 21, 285-294 ⁇ as well as termination signals such as the polyadenylation signal of the Ti plasmid pT ⁇ ACH5 ⁇ Gielen et al., 1984. EMBO J. 2, 835-846 ⁇ and translation enhancers such as the 5 'guide sequence from tobacco mosaic virus ⁇ Gallie et al. , 1987, Nucl. Acids Res. 15, 5 8693-8711 ⁇ .
- the proteins according to the invention are particularly suitable for the identification of herbicidal active substances, in particular for the detection of riosbose-5-phosphate isomerase-specific inhibitors.
- the proteins can be used, for example, in an enzyme test in which the activity of the rbose-5-phosphate isomerase is determined in the presence and absence of the active substance to be tested.
- a comparison of the two activity determinations 5 can be used to make a qualitative and quantitative statement about the inhibitory behavior of the active substance to be tested.
- the invention further relates to herbicides which can be identified using a test system described above.
- the invention also consists in a process for the preparation of herbicidal compositions which inhibit a vegetable r ⁇ bose-5-phosphate isomerase, which is characterized in that known chemical compounds are tested in a test described above and those with an inhibitory effect are customary with 0 Carrier and auxiliary substances formulated.
- the method reproducibly allows a large number of substances to be selectively selected from those with a high potency, in order to subsequently carry out further in-depth tests known to the person skilled in the art.
- the activity of the ribose 5-phosphate isomerase was determined in 40 mM potassium phosphate pH 7.4, 5 mM magnesium chloride, 0.5 U ribose 5-phosphate isomerase, 1 U transketolase, 1 U triose phosphate Isomerase and 1 U glycerol-3-phosphate dehydrogenase, 240 mM NADH, 10 mM R ⁇ bose-5-phosphate.
- R ⁇ bose-5-phosphate isomerase was obtained as a commercially available preparation (Sigma). The purification was carried out by ion exchange chromatography with DEAE 1 '- Fractogel (Merck) equilibrated in 10 mM potassium phosphate, pH 7.5, 10 mM ethylene diammotetraacetate (EDTA) and 10 mM 2-mercaptoethanol. After dialysis against column buffer, the protein was added to the column and eluted through a gradient of 0-0.3 M potassium chloride in column buffer. Fractions with R ⁇ bose-5-phosphate isomerase activity were concentrated using polyethylene glycol 20000 and then dialyzed against column buffer.
- the native molecular weight was determined via HPLC gel filtration at a flow rate of 1.0 ml / mm over Bio-Sil TSK 250 (Merck). The latter material was equilibrated in 50 mM sodium sulfate, 20 mM sodium dihydrogen phosphate pH 6.8. Beta-galactosidase (465 kD), immunoglobulin G (150 kD), antigen-binding antibody fragment (Fab, 50 kD) and myoglobm (17 kD) were used as protein standards. The native molecular weight was determined by interpolation of the graph from the retention time against the logarithm of the molecular weight.
- Purified protein was cleaved using cyanogen bromide or with endoprotemase LysC as described ⁇ Eckerskorn and Lott arrived, 1989, Chromatographia 28,
- the resulting peptides were separated using a 2 x 125 mm Supersher 60 RP select B column (Merck). A flow rate of 200 ⁇ l / mm m and a 1% / mm gradient of trifluoroacetic acid (0.1% (v / v)) in water and trifluoroacetic acid (0.1% (v / v)) in acetonitrile were used .
- the resulting peptides were degraded in an automatic Porton 3600 sequencer (Beckman) via amino terminal degradation ⁇ Edman and Begg, 1967, Eur. J. Biochem., 80-91 ⁇ and the amino acids were identified using the Microbore HPLC System Gold (Beckman) .
- Cloning processes such as restriction cleavage, agarose gel electrophoresis, purification of DNA fragments, transfer of nucleic acids to nitrocellulose and nylon membranes, ligation approaches, transformation of E. coli cells, cultivation of bacteria, multiplication of phages and sequence analysis of recombinant DNA were carried out as in Sambrook et al. (1989) ⁇ Cold Spring Harbor Laboratory Press: ISBN 0-87969-309-6 ⁇ .
- the PCR amplification of the R ⁇ bose-5-phosphate isomerase was carried out in a DNA thermal cycler from Perkm Elmer.
- the oligonucleotides used are shown in Figure 5.
- the reaction mixtures contained 8 ng / 1 double-stranded leaf-specific spinach cDNA, 0.5 ⁇ M of the corresponding oligonucleotides, 50 ⁇ M
- Nucleotides (Pharmacia), 50 mM potassium chloride, 10 mM Tris-HCl (pH 8.3 at 25 ° C), 1.5 mM magnesium chloride, and 0.02 U / 1 Taq polymerase (Perkin Elmer).
- the amplification conditions were set as follows: Addition temperature ' : 45 ° C, 1 min denaturation temperature: 92 ° C, 1 min elongation temperature: 72 ° C, 1 min number of cycles: 35
- the above sequence of 119 base pairs was used as hybridization probe (Clal / Xhol fragment of the plasmid pPCRrpil), which was carried out with the aid of a “Multiprime DNA labeling System” (Amersham Buchler) in the presence of ⁇ - 32 P-dCTP (Amersham; specific activity 3000 Ci / mmol) were radioactively labeled according to the manufacturer's instructions.
- the membranes were hybridized after prehybridization at 60 ° C.
- the sequencing of recombinant DNA molecules was carried out with an automatic laser fluorescence DNA sequencer (A.L.F.) from Pharmacia using fluorescent
- the DNA sequence of the longest cDNA sequence of the clone pRI12 is shown in SEQ ID N01 (Genbank Accession number L43068).
- the 1118 base pair long cDNA clone pRI12 contains an open reading frame of 870 bases and codes for a protein with 239 amino acids.
- Analysis of the polypeptide using the peptide sequences of the microsequencing showed that a sequence with typical characteristics of a chloroplastic transit peptide of 50 amino acids is present at the N-termmus of the protein.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU25055/97A AU2505597A (en) | 1996-03-29 | 1997-03-26 | Ribose-5-phosphate isomerase (d-ribose-5-phosphate ketol isomerase, ec 5.3.1.6) |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19612772.6 | 1996-03-29 | ||
| DE19612772 | 1996-03-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO1997037028A2 true WO1997037028A2 (fr) | 1997-10-09 |
| WO1997037028A3 WO1997037028A3 (fr) | 1997-12-04 |
Family
ID=7790003
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP1997/001539 WO1997037028A2 (fr) | 1996-03-29 | 1997-03-26 | Ribose-5-phosphate isomerase (d-ribose-5-phosphate cetol isomerase, ec 5.3.1.6) |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2505597A (fr) |
| WO (1) | WO1997037028A2 (fr) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100896968B1 (ko) * | 2007-03-21 | 2009-05-14 | 건국대학교 산학협력단 | 라이보스 5-인산 이성화효소를 이용한 알로스의 제조방법 |
| US7655770B1 (en) * | 1998-04-29 | 2010-02-02 | Monsanto Technology Llc | Nucleic acid molecules and other molecules associated with the phosphogluconate pathway |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1165713A1 (ru) * | 1983-02-25 | 1985-07-07 | Институт физиологии и биофизики растений АН ТаджССР | Способ получени рибозо-5-фосфат изомеразы из листьев шпината |
-
1997
- 1997-03-26 WO PCT/EP1997/001539 patent/WO1997037028A2/fr active Application Filing
- 1997-03-26 AU AU25055/97A patent/AU2505597A/en not_active Abandoned
Non-Patent Citations (7)
| Title |
|---|
| APEL TW ET AL: "The ribose 5-phosphate isomerase-encoding gene is located immediately downstream form that encoding murine immunoglobulin kabba" GENE, Bd. 156, 1995, AMSTERDAM NL, Seiten 191-197, XP002036260 in der Anmeldung erwähnt * |
| CHEMICAL ABSTRACTS, vol. 103, no. 17, 28.Oktober 1985 Columbus, Ohio, US; abstract no. 137700, IVANISHCHEV, V. V. ET AL: "Isolation of ribose 5-phosphate isomerase from spinach leaves" XP002036262 & SU 1 165 713 A (USSR) * |
| MARTIN W ET AL: "Microsequencing and cDNA cloning of the Calvin cycle/OPPP enzyme ribose-5-phosphate isomerase (EC 5.3.1.6) from spinach chloroplasts." PLANT MOL BIOL, FEB 1996, 30 (4) P795-805, NETHERLANDS, XP002036257 * |
| RUTNER A C: "SPINACH-D 5 PHOSPHO RIBOSE ISOMERASE PURIFICATION AND PROPERTIES OF THE ENZYME" BIOCHEMISTRY, 9 (1). 1970 178-184., XP002036259 in der Anmeldung erwähnt * |
| SCHNARRENBERGER C ET AL: "Enzymatic evidence for a complete oxidative pentose phosphate pathway in chloroplasts and an incomplete pathway in the cytosol of spinach leaves" PLANT PHYSIOLOGY (ROCKVILLE), 108 (2). 1995. 609-614., XP002036258 in der Anmeldung erwähnt * |
| SORENSEN KI ET AL: "Ribose catabolism of Escherichia coli: characterization of the rpiB gene encoding ribose phosphate isomerase B and of the rpiR gene, which is involved in regulation of rpiB expression" JOURNAL OF BACTERIOLOGY, Bd. 178, Nr. 4, Februar 1996, US, Seiten 1003-1011, XP002036261 in der Anmeldung erwähnt * |
| WOODRUFF WW 3D ET AL: "Inhibition of ribose-5-phosphate isomerase by 4-phosphoerythronate." J BIOL CHEM, JUL 10 1979, 254 (13) P5866-7, UNITED STATES, XP002043068 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7655770B1 (en) * | 1998-04-29 | 2010-02-02 | Monsanto Technology Llc | Nucleic acid molecules and other molecules associated with the phosphogluconate pathway |
| KR100896968B1 (ko) * | 2007-03-21 | 2009-05-14 | 건국대학교 산학협력단 | 라이보스 5-인산 이성화효소를 이용한 알로스의 제조방법 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997037028A3 (fr) | 1997-12-04 |
| AU2505597A (en) | 1997-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| McMichael et al. | Identification of the major regulatory phosphorylation site in sucrose-phosphate synthase | |
| Della-Cioppa et al. | Translocation of the precursor of 5-enol pyruvylshikimate-3-phosphate synthase into chloroplasts of higher plants in vitro | |
| Takahashi et al. | Cloning two genes for nicotianamine aminotransferase, a critical enzyme in iron acquisition (Strategy II) in graminaceous plants | |
| Sachs et al. | Anaerobic gene expression and flooding tolerance in maize | |
| US6942994B2 (en) | Materials and methods for the alteration of enzyme and acetyl CoA levels in plants | |
| Long et al. | Cloning and analysis of the C4 photosynthetic NAD-dependent malic enzyme of amaranth mitochondria. | |
| Lippmann et al. | Prokaryotic elongation factor Tu is phosphorylated in vivo. | |
| Gross et al. | Characterization, cloning, and evolutionary history of the chloroplast and cytosolic class I aldolases of the red alga Galdieria sulphuraria | |
| EP0723017A2 (fr) | Transcétolase | |
| Hlousek-Radojcic et al. | Expression of constitutive and tissue-specific acyl carrier protein isoforms in Arabidopsis | |
| Hallmann et al. | An inducible arylsulfatase of Volvox carteri with properties suitable for a reporter‐gene system: Purification, characterization and molecular cloning | |
| EP0368506A2 (fr) | ADP glucose-pyrophosphorylase | |
| Shibahara et al. | Identification of the 19S regulatory particle subunits from the rice 26S proteasome | |
| Pelzer-Reith et al. | Plant aldolase: cDNA and deduced amino-acid sequences of the chloroplast and cytosol enzyme from spinach | |
| DE19502053A1 (de) | Verfahren und DNA-Moleküle zur Steigerung der Photosyntheserate in Pflanzen, sowie Pflanzenzellen und Pflanzen mit gesteigerter Photosyntheserate | |
| McKean et al. | Molecular characterization of the non-biotin-containing subunit of 3-methylcrotonyl-CoA carboxylase | |
| Ishibashi et al. | Rice UV-damaged DNA binding protein homologues are most abundant in proliferating tissues | |
| Noma et al. | cDNA cloning and tissue-specific expression of the gene encoding human adenylate kinase isozyme 2 | |
| Godl et al. | Differential targeting of closely related ECM glycoproteins: the pherophorin family from Volvox | |
| Kato et al. | Novel actin-related proteins in vertebrates: similarities of structure and expression pattern to Arp6 localized on Drosophila heterochromatin | |
| WO1997037028A2 (fr) | Ribose-5-phosphate isomerase (d-ribose-5-phosphate cetol isomerase, ec 5.3.1.6) | |
| Watillon et al. | Cloning and characterization of an apple (Malus domestica (L.) Borkh) cDNA encoding a calmodulin-binding protein domain similar to the calmodulin-binding region of type II mammalian Ca2+/calmodulin-dependent protein kinase | |
| Zhang et al. | Proteomic analysis of interactions between the generalist herbivore Spodoptera exigua (Lepidoptera: Noctuidae) and Arabidopsis thaliana | |
| Cicicopol et al. | Primary structure of a multimeric protein, homologous to the PEP‐utilizing enzyme family and isolated from a hyperthermophilic archaebacterium | |
| Gasperi et al. | Isolation and partial characterization of two alcohol dehydrogenase isozymes from the medfly Ceratitis capitata |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU BG BR CA CN CZ GE HU IL JP KR LV MX NO NZ PL RO SG SI SK TR UA US AM AZ BY KG KZ MD RU TJ TM |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
| AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU BG BR CA CN CZ GE HU IL JP KR LV MX NO NZ PL RO SG SI SK TR UA US AM AZ BY KG KZ MD RU TJ TM |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 97534910 Format of ref document f/p: F |
|
| NENP | Non-entry into the national phase |
Ref country code: CA |
|
| 122 | Ep: pct application non-entry in european phase |